Drugs Online » Prescription Drugs 3 » Calcitriol Generic Rocaltrol
Indications1. Established postmenopausal osteoporosis. 2. Renal osteodystrophy in patients with chronic renal failure particularly those undergoing haemodialysis. 3. Secondary hyperparathyroidism in patients with moderate to severe chronic renal failure (pre-dialysis). 4. Postsurgical hypoparathyroidism. 5. Idiopathic hypoparathyroidism. 6. Pseudohypoparathyroidism. 7. Vitamin D-dependent rickets. 8. Hypophosphataemic vitamin D-resistant rickets. 9. Prevention of corticosteroid induced osteoporosis.
Buy Calcitriol Generic Rocaltrol and other Prescription Drugs 3 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Calcitriol Generic Rocaltrol:
Product Type: Prescription Drugs 3
Calcitriol( Generic Rocaltrol )
Calcitriol (Generic Rocaltrol)
Generic Rocaltrol
0.25mcg 90(3 x 30) Capsules 30 Capsules 0.5mcg 100 Capsules 200(2 x 100) Caps
Generic Rocaltrol Calcitriol

View more
Prescription Drugs 3
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|